chitosan has been researched along with nile red in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Cui, K; Cui, W; Lu, Q; Lu, X; Wei, Y; Wu, J | 1 |
Bodur, E; Caban, S; Capan, Y; Dalkara, T; Gürsoy-Özdemir, Y; Yemişci, M | 1 |
Bonferoni, MC; Caramella, C; Contri, RV; D'Autilia, F; Frank, AG; Frank, LA; Guterres, SS; Pohlmann, AR; Sandri, G | 1 |
Bianco-Peled, H; Delmar, K | 1 |
Cheng, B; Hu, F; Hu, Y; Liu, N; Tan, Y; Wen, L; Yuan, H | 1 |
Beck, RCR; Chiu, WS; da Silva, CB; Delgado-Charro, MB; Flores, FC | 1 |
Chen, G; Chen, W; Ding, S; Wang, J; Wen, L; Xie, S; Yang, F | 1 |
Alvi, SB; Jogdand, A; Rajalakshmi, PS; Rengan, AK | 1 |
8 other study(ies) available for chitosan and nile red
Article | Year |
---|---|
Photosensitive nanoparticles of chitosan complex for controlled release of dye molecules.
Topics: Butyrates; Chitosan; Drug Delivery Systems; Fluorescent Dyes; Microscopy, Electron, Transmission; Nanoparticles; Oxazines; Particle Size; Photochemical Processes; Spectrometry, Fluorescence; Ultraviolet Rays | 2011 |
Transport of a caspase inhibitor across the blood-brain barrier by chitosan nanoparticles.
Topics: Animals; Antibodies, Monoclonal; Blood-Brain Barrier; Brain; Caspase Inhibitors; Chitosan; Cysteine Proteinase Inhibitors; Male; Mice; Microscopy, Electron; Microscopy, Fluorescence; Nanoparticles; Neuroprotective Agents; Oxazines; Streptavidin | 2012 |
Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery.
Topics: Acrylic Resins; Animals; Chitosan; Female; Models, Biological; Mucous Membrane; Nanocapsules; Oxazines; Polymethacrylic Acids; Swine; Vagina; Vaginal Creams, Foams, and Jellies | 2014 |
Composite chitosan hydrogels for extended release of hydrophobic drugs.
Topics: Chitosan; Curcumin; Drug Carriers; Drug Liberation; Hydrogels; Hydrophobic and Hydrophilic Interactions; Oxazines | 2016 |
Sequential delivery of therapeutic agents using a rationally designed disulfide-linked glycolipid-like nanocarrier.
Topics: Adsorption; Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Survival; Chitosan; Disulfides; Drug Compounding; Drug Liberation; Female; Gene Transfer Techniques; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Nanoconjugates; Nanomedicine; Oxazines; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Small Interfering; RNAi Therapeutics; Static Electricity; Stearic Acids; Surface Properties; Time Factors; Transfection | 2016 |
Enhancement of tioconazole ungual delivery: Combining nanocapsule formulation and nail poration approaches.
Topics: Administration, Topical; Antifungal Agents; Chitosan; Drug Delivery Systems; Drug Liberation; Fluorescent Dyes; Humans; Imidazoles; Nails; Nanocapsules; Oxazines; Permeability | 2018 |
Is oval window transport a royal gate for nanoparticle delivery to vestibule in the inner ear?
Topics: Animals; Cell Line; Cell Survival; Chitosan; Cochlea; Drug Carriers; Drug Liberation; Fluorescent Dyes; Guinea Pigs; Hair Cells, Auditory; Humans; Hydrogels; Injection, Intratympanic; Mice; Nanoparticles; Oval Window, Ear; Oxazines; Perilymph; Permeability; Poloxamer; Tissue Distribution; Vestibular Diseases; Vestibule, Labyrinth | 2019 |
NIR-dye based mucoadhesive nanosystem for photothermal therapy in breast cancer cells.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line; Cell Survival; Chitosan; Female; Fluorescent Dyes; Humans; Infrared Rays; Liposomes; Mice; Microscopy, Fluorescence; Mucins; Nanoparticles; Oxazines; Photosensitizing Agents; Photothermal Therapy | 2020 |